Amyloid β Peptide Peptides
| Cat. No. | Product Name / Activity |
|---|---|
| 6550 | AC 253 |
| Prevents Aβ-induced neuronal death; amylin receptor antagonist | |
| 3391 | Amyloid β-peptide (42-1) (human) |
| Inactive control peptide for amyloid β-peptide (1-42) (Cat. No. 1428) | |
| 7031 | Amyloid β-Peptide (1-37) (human) New |
| Amyloid β-protein fragment | |
| 1191 | Amyloid β-Peptide (1-40) (human) |
| Amyloid β-protein fragment | |
| 2424 | Amyloid β-peptide (1-40) (rat) |
| Amyloid β-protein fragment | |
| 1428 | Amyloid β-Peptide (1-42) (human) |
| Predominant amyloid β-protein fragment | |
| 2425 | Amyloid β-peptide (1-42) (rat) |
| Predominant amyloid β-protein fragment | |
| 1938 | Amyloid β-Peptide (1-43) (human) |
| Amyloid β-protein fragment | |
| 1894 | Amyloid β-Peptide (12-28) (human) |
| Amyloid β-peptide; minimum required for binding to brain proteins | |
| 1429 | Amyloid β-peptide (25-35) (human) |
| Human amyloid β-protein fragment functionally required for neurotoxicity | |
| 6549 | cAC 253 |
| Inhibits Aβ-induced neuronal death; amylin receptor antagonist | |
| 3945 | Colivelin |
| Neuroprotective peptide; protects against β-amyloid neurotoxicity | |
| 4084 | LPYFD-NH2 |
| Binds Aβ; protects from aggregation induced toxicity |